SEC Form 4 · accession 0001209191-15-037043
BIOLASE, INC · BIOL
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Paul N Clark
Director
Period of report
Apr 27, 2015
Accepted (ET)
Apr 29, 2015 · 5:03 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000811240
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $2.27 | Apr 27, 2015 | A | 254,405 | A | — | Apr 27, 2025 | Common Stock | 254,405 | 319,583 | D |
Explanation of responses
- F1The stock option vests and is exercisable in equal monthly installments over a consecutive 12-month period, commencing one month from the date of grant.